Showing 321 - 340 results of 100,659 for search '(( 5 we decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.66s Refine Results
  1. 321
  2. 322

    Table_5_Decrease of Clone Diversity in IgM Repertoires of HBV Chronically Infected Individuals With High Level of Viral Replication.pdf by Binbin Hong (9989819)

    Published 2021
    “…To investigate the characteristics of antibody repertoires in patients with chronic HBV infection, we performed Illumina sequencing and IMGT/HighV-QUEST analysis of B lymphocytes from healthy adults and the HBV carriers with high or low level of viral replication. …”
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328

    Breast Cancer 1 (BrCa1) May Be behind Decreased Lipogenesis in Adipose Tissue from Obese Subjects by Francisco J. Ortega (161440)

    Published 2012
    “…Consistent with its role limiting fatty acid biosynthesis, both <em>BrCa1</em> mRNA (3.5-fold, p<0.0001) and protein (1.2-fold, p = 0.001) were increased in pre-adipocytes, and decreased during <em>in vitro</em> adipogenesis, while P-ACC decreased during differentiation of human adipocytes (p = 0.005) allowing lipid biosynthesis. …”
  9. 329
  10. 330

    Table_1_Urban-driven decrease in arthropod richness and diversity associated with group-specific changes in arthropod abundance.DOCX by Marion Chatelain (3317994)

    Published 2023
    “…Urbanisation level was estimated by five different proxies extracted from land use/land cover data (e.g., impervious surface cover), all of them calculated in a 100, 500, and 1,000 m radius around the sampling points, and three indexes based on distance to settlements. …”
  11. 331

    Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination by Cheng Cheng (68821)

    Published 2012
    “…Thus, understanding Ad seropositivity in humans is important to the development of an AIDS vaccine. Here, we analyze the impact of different Ad5-specific neutralizing antibodies on immune function and clinical outcome.…”
  12. 332
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340